During the past decade, Instituto de Oncologia de Piracicaba S/S Ltda. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Oncologia de Piracicaba S/S Ltda." #1 collaborator was "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Oncologia de Piracicaba S/S Ltda." are "BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials), "Breast Neoplasms" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Instituto de Oncologia de Piracicaba S/S Ltda." in a lesser frequency.

Most popular intervention types in "Instituto de Oncologia de Piracicaba S/S Ltda." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Interferon-Alfa 9MU" (1 trials), "Physician's-Choice" (1 trials), "Temsirolimus" (1 trials) and "talazoparib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Oncologia de Piracicaba S/S Ltda." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Oncologia de Piracicaba S/S Ltda.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto de Oncologia de Piracicaba S/S Ltda., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Oncologia de Piracicaba S/S Ltda., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".